Filter
524
Text search:
pharmacovigilance
Featured
Recommendations
56
New Publications
146
Language
Document type
No document type
237
Guidelines
108
Studies & Reports
67
Strategic & Response Plan
37
Manuals
33
Fact sheets
15
Training Material
9
Resource Platforms
8
Situation Updates
4
Online Courses
4
Infographics
2
Countries / Regions
Kenya
23
Global
18
Ghana
16
Congo, Democratic Republic of
15
Uganda
15
India
15
Western and Central Europe
13
Nigeria
12
Namibia
12
Ethiopia
11
South Africa
11
Eastern Europe
11
Senegal
9
Nepal
9
Rwanda
9
Latin America and the Carribbean
9
Zambia
8
West and Central Africa
8
Sierra Leone
7
Tanzania
7
Malawi
7
Madagascar
7
Burkina Faso
6
Haiti
6
Benin
6
East and Southern Africa
6
Cambodia
5
South–East Asia Region
5
Liberia
4
Bangladesh
4
Middle East and North Africa
4
Africa
4
Russia
4
Cameroon
3
Zimbabwe
3
Ukraine
3
Botswana
3
Lesotho
3
Eastern Europe and Central Asia
3
Guinea
2
Mali
2
Morocco
2
Philippines
2
Syria
2
Indonesia
2
Mozambique
2
Sudan
2
Eswatini/ Swaziland
2
Brazil
2
Burundi
2
Myanmar / Burma
2
Chile
2
Paraguay
2
Asia
2
Côte d’Ivoire / Ivory Coast
1
Togo
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Chad
1
Thailand
1
Gambia
1
Central African Republic
1
Argentina
1
Libya
1
Sri Lanka
1
Yemen
1
Western Pacific Region
1
Bhutan
1
Southern Africa
1
Laos
1
Georgia
1
Vietnam
1
France
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
257
Clinical Guidelines
55
Public Health
11
Pharmacy & Technologies
10
Capacity Building
8
Key Resources
7
Women & Child Health
6
Toolboxes
Pharmacy
68
COVID-19
56
TB
51
Malaria
39
AMR
37
NTDs
24
HIV
23
Ebola & Marburg
5
NCDs
5
Rapid Response
4
Refugee
3
Caregiver
3
Planetary Health
3
Specific Hazards
2
Cholera
1
Polio
1
Conflict
1
Global Health Education
1
2.0 Rapid Response
1
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Group
10–21 March 2014
August 2020, The Africa Joint Continental Strategy for COVID-19 is underpinned by the need to limit transmission, prevent deaths and reduce associated harms. Participation by African nations in clinical trials is an essential step to ensure that sufficient data is generated on the safety and efficac
...
Pharmaceutical profile of DRC
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID
...
This manual summarizes key issues related to the safety of NTD medicines and their administration, with a focus on essential medicines used in mass drug administration (MDA), also called preventive chemotherapy. It can be used as a standalone reference manual, but is intended to be used in conjuncti
...
Framework for implementation.
The END TB Strategy.
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe
...
Global UNIDO Project: Strengthening the local production of essential medicines in least developed and developing countries
Third Edition
Drugs & Therapy Perspectives vol.36 (2020) 6
The Access to COVID-19 Tools (ACT) Accelerator’s Country Readiness and Delivery workstream has released guidance on developing a national deployment and vaccination plan (NDVP) for COVID-19 vaccines. This course is intended to help national and sub-national focal points in countries develop the ND
...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Antimicrobial resistance (AMR) is occurring everywhere in the world, compromising the ability to treat infectious diseases, as well as undermining many other advances in health and medicine. Underlying factors that drive AMR include; weak or absent surveillance and monitoring systems, inadequate sys
...
